Stifel Reiterates Hold Rating on Fate Therapeutics (FATE)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
| FATE THERAPEUTICS (NASDAQ: FATE) | Delayed: 2.06 -0.05 (2.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.11 | 52 Week High | $4.76 | |||
| Open | $2.10 | 52 Week Low | $1.46 | |||
| Day High | $2.14 | P/E | N/A | |||
| Day Low | $2.04 | EPS | $-1.91 | |||
| Volume | 1,460,282 | |||||
